J&J's Win Upheld In Antibody Patent Fight Against Abbott
U.S. District Judge F. Dennis Saylor rejected various post-trial motions filed by Abbott, which had accused Janssen of infringing the two patents by selling the psoriasis treatment Stelara. The decision means the jury's September verdict that both patents were invalid will be entered as final judgment.
Abbott had asked for...
To view the full article, register now.